Anika Therapeutics, Inc.
DE ˙ DB ˙ US0352551081
11,90 € ↓ -0,30 (-2,46%)
2026-06-03
DEL PRIS
SecurityDE:AKP / Anika Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership133,074 shares
Latest Disclosed Value $ 1,929,574
UBS Group AG ownership in AKP / Anika Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 133,074 shares of Anika Therapeutics, Inc. (DE:AKP) valued at $1,610,195 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 28,545 shares of Anika Therapeutics, Inc.. This represents a change in shares of 366.19% during the quarter. The current value of the position is $1,583,581 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (AKP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:AKP / Anika Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ANIKA THERAPEUTICS COM 035255108 133,074 104,529 366.19 1,930 604.01 0.0001
2026-01-29 2025-12-31 13F ANIKA THERAPEUTICS COM 035255108 28,545 -238 -0.83 274 1.48 0.0000
2025-11-13 2025-09-30 13F ANIKA THERAPEUTICS COM 035255108 28,783 -62,284 -68.39 271 -71.96 0.0000
2025-08-14 2025-06-30 13F ANIKA THERAPEUTICS COM 035255108 91,067 77,015 548.07 963 356.40 0.0002
2025-05-13 2025-03-31 13F ANIKA THERAPEUTICS COM 035255108 14,052 -54,672 -79.55 211 -81.34 0.0000
2025-02-14 2024-12-31 13F ANIKA THERAPEUTICS COM 035255108 68,724 61,184 811.46 1,131 508.06 0.0002
2024-11-14 2024-09-30 13F ANIKA THERAPEUTICS COM 035255108 7,540 451 6.36 186 3.91 0.0000
2024-08-14 2024-06-30 13F ANIKA THERAPEUTICS COM 035255108 7,089 -11,640 -62.15 180 -62.32 0.0000
2024-05-13 2024-03-31 13F ANIKA THERAPEUTICS COM 035255108 18,729 3,383 22.04 476 36.89 0.0001
2024-02-09 2023-12-31 13F ANIKA THERAPEUTICS COM 035255108 15,346 5,970 63.67 348 99.43 0.0001
2023-11-09 2023-09-30 13F ANIKA THERAPEUTICS COM 035255108 9,376 -13,963 -59.83 175 -71.29 0.0001
2023-08-11 2023-06-30 13F ANIKA THERAPEUTICS COM 035255108 23,339 3,393 17.01 606 5.94 0.0002
2023-05-12 2023-03-31 13F ANIKA THERAPEUTICS COM 035255108 19,946 -4,964 -19.93 573 -22.39 0.0002
2023-02-08 2022-12-31 13F ANIKA THERAPEUTICS COM 035255108 24,910 19,129 330.89 737 437.96 0.0003
2022-11-10 2022-09-30 13F ANIKA THERAPEUTICS COM 035255108 5,781 825 16.65 137 24.55 0.0001
2022-08-10 2022-06-30 13F ANIKA THERAPEUTICS COM 035255108 4,956 -24,207 -83.01 110 -84.97 0.0000
2022-05-16 2022-03-31 13F ANIKA THERAPEUTICS COM 035255108 29,163 -613 -2.06 732 -31.33 0.0002
2022-02-14 2021-12-31 13F ANIKA THERAPEUTICS COM 035255108 29,776 9,339 45.70 1,066 22.53 0.0003
2021-11-15 2021-09-30 13F ANIKA THERAPEUTICS COM 035255108 20,437 10,322 102.05 870 98.63 0.0003
2021-08-13 2021-06-30 13F ANIKA THERAPEUTICS COM 035255108 10,115 -9,450 -48.30 438 -45.11 0.0001
2021-05-12 2021-03-31 13F ANIKA THERAPEUTICS COM 035255108 19,565 18,579 1,884.28 798 1,673.33 0.0003
2021-02-11 2020-12-31 13F ANIKA THERAPEUTICS COM 035255108 986 -1,127 -53.34 45 -40.00 0.0000
2020-11-12 2020-09-30 13F ANIKA THERAPEUTICS COM 035255108 2,113 938 79.83 75 70.45 0.0000
2020-07-31 2020-06-30 13F ANIKA THERAPEUTICS COM 035255108 1,175 -5,741 -83.01 44 -78.00 0.0000
2020-05-01 2020-03-31 13F ANIKA THERAPEUTICS COM 035255108 6,916 3,156 83.94 200 2.56 0.0001
2020-02-14 2019-12-31 13F ANIKA THERAPEUTICS COM 035255108 3,760 -33,524 -89.92 195 -90.47 0.0001
2019-11-14 2019-09-30 13F ANIKA THERAPEUTICS COM 035255108 37,284 18,909 102.91 2,046 173.90 0.0008
2019-08-14 2019-06-30 13F ANIKA THERAPEUTICS COM 035255108 18,375 -90,757 -83.16 747 -77.36 0.0003
2019-05-14 2019-03-31 13F ANIKA THERAPEUTICS COM 035255108 109,132 37,662 52.70 3,300 37.39 0.0014
2019-02-14 2018-12-31 13F ANIKA THERAPEUTICS COM 035255108 71,470 8,616 13.71 2,402 -9.39 0.0011
2018-11-14 2018-09-30 13F ANIKA THERAPEUTICS COM 035255108 62,854 10,735 20.60 2,651 58.93 0.0011
2018-08-14 2018-06-30 13F ANIKA THERAPEUTICS COM 035255108 52,119 49,026 1,585.06 1,668 983.12 0.0007
2018-05-15 2018-03-31 13F ANIKA THERAPEUTICS COM 035255108 3,093 -1,660 -34.93 154 -39.84 0.0001
2018-02-14 2017-12-31 13F ANIKA THERAPEUTICS COM 035255108 4,753 2,189 85.37 256 72.97 0.0001
2017-11-14 2017-09-30 13F ANIKA THERAPEUTICS COM 035255108 2,564 757 41.89 148 66.29 0.0001
2017-11-14 2017-06-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 1,807 86 5.00 89 18.67 0.0000
2017-08-14 2017-06-30 13F ANIKA THERAPEUTICS COM 035255108 1,807 86 89
2017-11-14 2017-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 1,721 -1,238 -41.84 75 -48.28 0.0000
2017-05-12 2017-03-31 13F ANIKA THERAPEUTICS COM 035255108 1,721 -1,238 75
2017-02-14 2016-12-31 13F ANIKA THERAPEUTICS COM 035255108 2,959 -12 -0.40 145 2.11 0.0001
2016-11-14 2016-09-30 13F ANIKA THERAPEUTICS COM 035255108 2,971 922 45.00 142 30.28 0.0001
2016-08-12 2016-06-30 13F ANIKA THERAPEUTICS COM 035255108 2,049 -14,587 -87.68 109 -85.35 0.0001
2016-05-12 2016-03-31 13F ANIKA THERAPEUTICS COM 035255108 16,636 14,967 896.76 744 1,080.95 0.0005
2016-02-16 2015-12-31 13F ANIKA THERAPEUTICS COM 035255108 1,669 -875 -34.39 63 -23.17 0.0000
2015-11-13 2015-09-30 13F ANIKA THERAPEUTICS COM 035255108 2,544 415 19.49 82 17.14 0.0001
2015-08-14 2015-06-30 13F ANIKA THERAPEUTICS COM 035255108 2,129 -12,680 -85.62 70 -88.51 0.0000
2015-05-14 2015-03-31 13F ANIKA THERAPEUTICS COM 035255108 14,809 -9,352 -38.71 609 -38.11 0.0004
2015-02-17 2014-12-31 13F ANIKA THERAPEUTICS COM 035255108 24,161 24,161 984 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-08-14 2015-06-30 13F ANIKA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F ANIKA THERAPEUTICS COM Call 800 -11.11 33 -10.81 n/a n/a n/a
2015-02-17 2014-12-31 13F ANIKA THERAPEUTICS COM Call 900 37 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.